Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Norihito Inoue
Observed names:
N Inoue,
N. Inoue
Institutions:
The Cancer Institute Hospital,
Japanese Foundation For Cancer Research
Observed institutions:
The Cancer Institute Hospital,
Japanese Foundation For Cancer Research
ORCID:
0009-0004-0017-5086
Observed ORCID:
0009-0004-0017-5086
OpenAlex ID:
A5005774959
Works
65
Awards
1
Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma
2017
·
Y Kusano
, M Yokoyama
, et al.
·
Blood Cancer Journal
·
37
PDF
Incidence and risk factors for febrile neutropenia in Japanese patients with non-Hodgkin B cell lymphoma receiving R-CHOP: 2-year experience in a single center (STOP FN in NHL 2)
2019
·
Masahiro Yokoyama
, Yoshiharu Kusano
, et al.
·
Supportive Care in Cancer
·
24
PDF
Incidence and risk factors of febrile neutropenia in patients with non-Hodgkin B-cell lymphoma receiving R-CHOP in a single center in Japan
2017
·
Masahiro Yokoyama
, Yoshiharu Kusano
, et al.
·
Supportive Care in Cancer
·
20
PDF
High pretreatment level of soluble interleukin-2 receptor is a robust prognostic factor in patients with follicular lymphoma treated with R-CHOP-like therapy
2017
·
Y Kusano
, M Yokoyama
, et al.
·
Blood Cancer Journal
·
17
PDF
Impact of Omission/Reduction of Vincristine From R-CHOP in Treatment of DLBCL
2020
·
Shoko Marshall
, Noriko Nishimura
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
12
MYD88 L265P mutation detected by digital PCR as a prognostic factor in patients with diffuse large B-cell lymphoma in rituximab era
2020
·
Noriko Nishimura
, Kengo Takeuchi
, et al.
·
Leukemia Research
·
12
Prognostic factors for primary cutaneous anaplastic large-cell lymphoma: a multicentre retrospective study from Japan
2023
·
Tomomitsu Miyagaki
, Norihito Inoue
, et al.
·
British Journal of Dermatology
·
11
Bearing 19q13 aberration predicts poor prognosis in non‐germinal centre type of CD 5+ DLBCL
2017
·
Yuko Mishima
, Yasuhito Terui
, et al.
·
British Journal of Haematology
·
11
Rituximab Maintenance Therapy Is an Effective Therapy in over-Sixties with Mantle Cell Lymphoma
2015
·
Norihito Inoue
, Noriko Nishimura
, et al.
·
Blood
·
8
Roles of STAT3 and STAT Family Proteins and Their Signaling Pathways in Thyroid Cancer
2026
·
Chie Masaki
, Norihito Inoue
, et al.
·
Cells
·
7
The clonal evolution during long-term clinical course of multiple myeloma
2020
·
Yuko Mishima
, Yuji Mishima
, et al.
·
International Journal of Hematology
·
4
Multiple myeloma as a second primary malignancy; one fourth of patients had prior history of other malignances
2015
·
N. Nishimura
, Y. Terui
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
4
Constant small‐cell changes and variable LEF1 expression in DUSP22‐rearranged primary cutaneous anaplastic large‐cell lymphoma: Analysis of the repeated biopsies of three patients
2023
·
Akio Osakada
, Masakazu Fujimoto
, et al.
·
Pathology International
·
3
Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis)
2021
·
Masahiro Yokoyama
, Yoshiharu Kusano
, et al.
·
BMC Cancer
·
3
PDF
Angiotensin II receptor blockers might reduce a cardiotoxicity induced by carfilzomib: retrospective analysis of 17 cases
2019
·
Takanori Fukuta
, Noriko Nishimura
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
3
Delayed recovery of serum immunoglobulin G is a poor prognostic marker in patients with follicular lymphoma treated with rituximab maintenance
2017
·
Yoshiharu Kusano
, Masahiro Yokoyama
, et al.
·
Annals of Hematology
·
3
Quantitative analysis of MYD88 L265P mutations by digital PCR is an independent prognostic factor for CNS relapse as well as systemic relapse and poor outcome
2017
·
N. Nishimura
, R. Asaka
, et al.
·
Hematological Oncology
·
3
PDF
Clinical Features and Outcomes of Localized Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma: A Dual-Center Retrospective Observational Study with a Long-Term Follow-up
2024
·
Kikuaki Yoshida
, Noriko Iwaki
, et al.
·
Blood
·
2
PDF
Detection of TRAF1‐ALK fusion in skin lesions of systemic ALK + anaplastic large cell lymphoma initially involving the skin and the draining lymph node
2023
·
Yuta Norimatsu
, Taro Akatsuka
, et al.
·
The Journal of Dermatology
·
2
Durable response of therapy-related MDS/AML with concomitant Waldenström’s macroglobulinemia treated with venetoclax and azacitidine
2022
·
Mitsuhito Hirano
, Mikako Tamba
, et al.
·
Annals of Hematology
·
2
PDF
Progression-free survival at 24 months as a predictor of survival outcomes after CHOP treatment in patients with peripheral T-cell lymphoma: a single-center validation study in a Japanese population
2021
·
Yuko Shirouchi
, Masahiro Yokoyama
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
2
Impact of Creatinine Clearance in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP : A Real-World Long-Term Observation Analysis at a Single Institute
2018
·
Noriko Nishimura
, Takanori Fukuta
, et al.
·
Blood
·
2
Efficacy of chemotherapy in extremely elderly patients with diffuse large B-cell lymphoma.
2017
·
Anna Takahashi
, Yuko Mishima
, et al.
·
PubMed
·
2
80% Dose R-CHOP Is Suitable Chemotherapy for Very Elderly Patients with DLBCL
2015
·
Anna Takahashi
, Yuko Mishima
, et al.
·
Blood
·
2
The Presence of M Protein Is Strongly Associated with Very Poor Prognosis in Patients with Extranodal Diffuse Large B-Cell Lymphoma
2015
·
Hideaki Nitta
, Yasuhito Terui
, et al.
·
Blood
·
2
Show more works
View as search
Works count:
65
Citation count:
209
H-index:
8
I10-index:
8
Year
Topic
Type